Skip to main content

Table 2 Biochemical parameters of HCC and HCV cases

From: Plasminogen activator inhibitor (PAI-1) gene polymorphism (4G/5G) and hepatocellular carcinoma in Egyptian patients

Biochemical parameters

HCC patients

Control

p value

ALT (IU)

55.8 ± 49.4

50.4 ± 27.7

0.660

AST (IU)

106.4 ± 93.0

50.9 ± 26.3

< 0.001*

T. bilirubin (mg/dL)

4.5 ± 4.9

0.72 ± 0.4

< 0.001*

HB (g/dL)

9.7 ± 1.7

13.8 ± 1.4

< 0.001*

WBC (×103)

9.2 ± 5.4

6.5 ± 1.7

0.009*

Platelets (×103)

134.3 ± 99.5

242.5 ± 65.4

< 0.001*

PT (seconds)

23.0 ± 5.7

12.6 ± 0.8

< 0.001*

Albumin (g/dL)

2.2 ± 0.4

4.0 ± 0.6

< 0.001*

AFP (ng/mL)

1978.9 ± 3866.6

2.6 ± 2.7

< 0.001*

  1. HCC hepatocellular carcinoma, HCV hepatitis C virus, ALT alanine transaminase, AST aspartate transaminase, HB hemoglobin, WBC white blood cell, PT prothrombin time, AFT alphafetoprotein
  2. aMann-Whitney test
  3. *Statistically significant at p < 0.05